Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

The Lancet Oncology - Tập 9 - Trang 1039-1047 - 2008
Jing Ma1, Haojie Li2,3, Ed Giovannucci1,3, Lorelei Mucci4, Weiliang Qiu1, Paul L Nguyen5, J Michael Gaziano6,7, Michael Pollak8, Meir J Stampfer1,3
1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
2GlaxoSmithKline R&D, Worldwide Epidemiology (Oncology), Collegeville, PA, USA
3Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA, USA
4Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
5Harvard Radiation Oncology Program, Boston, MA, USA
6Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
7Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, MA, USA
8Cancer Prevention Research Unit, Departments of Medicine and Oncology, Lady Davis Research Institute of the Jewish General Hospital and McGill University, Montreal, Canada

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

The Lancet Oncology

Tập 9

1039-1047

Thông tin tác giả